Drugs / Purslane
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00746772 Comparator | Apr 2006 → May 2008 | lichen planus, oral | Qazvin University Of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Purslane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00746772 ↗ |
| Target | IL6 | “Purslane also decreased the level of TNF-α and IL6” NCT00746772 ↗ |
| Target | TNF | “Purslane also decreased the level of TNF-α and IL6” NCT00746772 ↗ |